221 related articles for article (PubMed ID: 10528146)
1. Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment.
Geurts M; Hermans E; Maloteaux JM
Eur J Pharmacol; 1999 Oct; 382(2):119-27. PubMed ID: 10528146
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of quinpirole-stimulated [35S]GTPgammaS binding: discrepancy with receptor binding profile.
Gilliland SL; Alper RH; Levant B
Eur J Pharmacol; 2000 Mar; 392(3):125-8. PubMed ID: 10762663
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization.
Koener B; Goursaud S; Van De Stadt M; Calas AG; Jeanjean AP; Maloteaux JM; Hermans E
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan; 383(1):65-77. PubMed ID: 21061116
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors.
Roberts DJ; Lin H; Strange PG
Biochem Pharmacol; 2004 May; 67(9):1657-65. PubMed ID: 15081865
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of dopamine-stimulated [35S]-guanosine 5'(gamma-thiotriphosphate) ([35S]GTPgammaS) binding in rat striatal membranes.
Rinken A; Finnman UB; Fuxe K
Biochem Pharmacol; 1999 Jan; 57(2):155-62. PubMed ID: 9890563
[TBL] [Abstract][Full Text] [Related]
6. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
[TBL] [Abstract][Full Text] [Related]
7. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
8. Characterization of dopaminergic compounds at hD2short, hD4.2 and hD4.7 receptors in agonist-stimulated [35S]GTPgammaS binding assays.
Gilliland SL; Alper RH
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):498-504. PubMed ID: 10832603
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor-modulated [35S]GTPgammaS binding in striatum of 6-hydroxydopamine-lesioned rats.
Geurts M; Hermans E; Cumps J; Maloteaux JM
Brain Res; 1999 Sep; 841(1-2):135-42. PubMed ID: 10546996
[TBL] [Abstract][Full Text] [Related]
10. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
Malmberg ; Mikaels ; Mohell N
J Pharmacol Exp Ther; 1998 Apr; 285(1):119-26. PubMed ID: 9536001
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the D2short dopamine receptor with G proteins: analysis of receptor/G protein selectivity.
Nickolls SA; Strange PG
Biochem Pharmacol; 2003 Apr; 65(7):1139-50. PubMed ID: 12663049
[TBL] [Abstract][Full Text] [Related]
12. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
Sóvágó J; Makkai B; Gulyás B; Hall H
Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
[TBL] [Abstract][Full Text] [Related]
13. Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia.
Andersson M; Terasmaa A; Fuxe K; Strömberg I
J Neurosci Res; 2005 Oct; 82(2):264-72. PubMed ID: 16175569
[TBL] [Abstract][Full Text] [Related]
14. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor.
Gazi L; Schoeffter P; Nunn C; Croskery K; Hoyer D; Feuerbach D
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):555-64. PubMed ID: 10832611
[TBL] [Abstract][Full Text] [Related]
15. Agonist-induced [35S]GTPgammaS binding in the membranes of Spodoptera frugiperda insect cells expressing the human D3 dopamine receptor.
Pregenzer JF; Alberts GL; Im WB
Neurosci Lett; 1997 Apr; 226(2):91-4. PubMed ID: 9159497
[TBL] [Abstract][Full Text] [Related]
16. Histamine H3 and dopamine D2 receptor-mediated [35S]GTPgamma[S] binding in rat striatum: evidence for additive effects but lack of interactions.
Humbert-Claude M; Morisset S; Gbahou F; Arrang JM
Biochem Pharmacol; 2007 Apr; 73(8):1172-81. PubMed ID: 17306767
[TBL] [Abstract][Full Text] [Related]
17. Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [35S]GTP gamma S binding.
Geurts M; Hermans E; Maloteaux JM
Life Sci; 1999; 65(16):1633-45. PubMed ID: 10573181
[TBL] [Abstract][Full Text] [Related]
18. 5-HT-stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes.
Odagaki Y; Toyoshima R
Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):335-45. PubMed ID: 16491386
[TBL] [Abstract][Full Text] [Related]
19. Alteration of dopamine transport in the striatum and nucleus accumbens of ovariectomized and estrogen-primed rats following N-(p-isothiocyanatophenethyl) spiperone (NIPS) treatment.
Thompson TL; Bridges SR; Weirs WJ
Brain Res Bull; 2001 Apr; 54(6):631-8. PubMed ID: 11403989
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
Odagaki Y; Toyoshima R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
